Target intelligence / Profile preview

Japanese encephalitis virus envelope protein E (E protein)

Target
E protein
Molecular classification
Viral envelope glycoprotein, Fusion protein, Other
01

Overview

Japanese encephalitis virus envelope protein E is a surface glycoprotein essential for viral infectivity. It is responsible for the initial binding of the virus to host cell receptors, membrane fusion during cell entry, and is the principal target of protective neutralizing antibodies. The E protein consists of three domains (DI, DII, DIII) and forms head-to-tail homodimers on mature virions. Domain III contains critical epitopes recognized by neutralizing monoclonal antibodies, making it a key target for vaccine development and therapeutic antibodies. Structural features of E protein influence viral stability, neurovirulence, and serocomplex-specific pathogenesis. These properties make the E protein a central focus in the prevention and treatment of Japanese encephalitis.

Other names
Japanese encephalitis virus E proteinEnvelope glycoprotein EJEV E protein
02

Mechanism of action

Inhibition of viral entry and fusion (neutralizing antibodies bind E protein, prevent receptor binding and membrane fusion) Induction of protective immunity (vaccines generate anti-E antibodies)

03

Biological functions

Viral attachmentMembrane fusionInduction of neutralizing antibody responseDeterminant of cell tropismMediator of immune evasion
04

Disease associations

InfectionNeurovirulenceViral pathogenesis
05

Safety considerations

Antibody-dependent enhancementMutational escape
06

Interacting drugs

Vaccines

1 more in the full profile.

07

Biomarkers

Anti-E protein antibody titers

Beyond the preview

Go deeper on Japanese encephalitis virus envelope protein E (E protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Japanese encephalitis virus envelope protein E (E protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call